Business Description
Innoviva Inc
NAICS : 325412
SIC : 2834
ISIN : US45781M1018
Share Class Description:
INVA: Ordinary SharesDescription
Innoviva Inc is a company with a portfolio of royalties and innovative healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others.
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.4 | |||||
Equity-to-Asset | 0.56 | |||||
Debt-to-Equity | 0.64 | |||||
Debt-to-EBITDA | 1.85 | |||||
Interest Coverage | 5.33 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 2.3 | |||||
Beneish M-Score | -2.74 | |||||
WACC vs ROIC |
Growth Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 6.4 | |||||
3-Year EBITDA Growth Rate | -6.2 | |||||
3-Year EPS without NRI Growth Rate | 1.1 | |||||
3-Year FCF Growth Rate | -16.3 | |||||
3-Year Book Growth Rate | 26 | |||||
Future 3-5Y EPS without NRI Growth Rate | -16.76 | |||||
Future 3-5Y Total Revenue Growth Rate | 3.79 |
Momentum Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 81.98 | |||||
9-Day RSI | 79.05 | |||||
14-Day RSI | 75.92 | |||||
6-1 Month Momentum % | -2.3 | |||||
12-1 Month Momentum % | 22.74 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 10.42 | |||||
Quick Ratio | 9.17 | |||||
Cash Ratio | 5.97 | |||||
Days Inventory | 363.11 | |||||
Days Sales Outstanding | 73.81 | |||||
Days Payable | 36.98 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | 14.5 | |||||
Shareholder Yield % | 10.11 |
Profitability Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 86.12 | |||||
Operating Margin % | 35.24 | |||||
Net Margin % | 58.21 | |||||
FCF Margin % | 48.8 | |||||
ROE % | 29.04 | |||||
ROA % | 15.25 | |||||
ROIC % | 10.21 | |||||
ROC (Joel Greenblatt) % | 227.18 | |||||
ROCE % | 18.96 | |||||
Years of Profitability over Past 10-Year | 8 |
GF Value Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 8.36 | |||||
PE Ratio without NRI | 8.32 | |||||
Shiller PE Ratio | 10.66 | |||||
Price-to-Owner-Earnings | 7.88 | |||||
PEG Ratio | 1.16 | |||||
PS Ratio | 4.7 | |||||
PB Ratio | 1.65 | |||||
Price-to-Tangible-Book | 2.52 | |||||
Price-to-Free-Cash-Flow | 9.68 | |||||
Price-to-Operating-Cash-Flow | 9.66 | |||||
EV-to-EBIT | 6.43 | |||||
EV-to-EBITDA | 5.79 | |||||
EV-to-Revenue | 4.52 | |||||
EV-to-FCF | 9.25 | |||||
Price-to-Projected-FCF | 0.44 | |||||
Price-to-Median-PS-Value | 0.76 | |||||
Price-to-Graham-Number | 0.97 | |||||
Earnings Yield (Greenblatt) % | 15.55 | |||||
FCF Yield % | 13.13 | |||||
Forward Rate of Return (Yacktman) % | 16.12 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:INVA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Innoviva Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 311.59 | ||
EPS (TTM) ($) | 2.22 | ||
Beta | 0.53 | ||
Volatility % | 23.09 | ||
14-Day RSI | 75.92 | ||
14-Day ATR ($) | 0.39939 | ||
20-Day SMA ($) | 16.9315 | ||
12-1 Month Momentum % | 22.74 | ||
52-Week Range ($) | 12.22 - 18.7 | ||
Shares Outstanding (Mil) | 62.44 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Innoviva Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Innoviva Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Innoviva Inc Frequently Asked Questions
What is Innoviva Inc(INVA)'s stock price today?
The current price of INVA is $18.54. The 52 week high of INVA is $18.70 and 52 week low is $12.22.
When is next earnings date of Innoviva Inc(INVA)?
The next earnings date of Innoviva Inc(INVA) is 2024-08-02 Est..
Does Innoviva Inc(INVA) pay dividends? If so, how much?
Innoviva Inc(INVA) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |